Editorial |

Hormone Replacement Therapy and Heart Disease Prevention:  Experimentation Trumps Observation

Diana B. Petitti, MD
JAMA. 1998;280(7):650-652. doi:10.1001/jama.280.7.650.
Text Size: A A A
Published online


Three different meta-analyses13 have concluded that estrogen replacement therapy (ERT) decreases the risk of coronary heart disease (CHD) by 35% to 50%. The predicted increase in life expectancy in hormone users, based on estimates of the risk of CHD in users of ERT derived from observational studies, is 2 to 3 years.2,4 The effects of ERT and combined estrogen-progestin replacement therapy (HRT) on lipids and fibrinolysis are strongly beneficial for both ERT and HRT.5 This has led to extrapolation of the results of observational studies of ERT to HRT and to promotion of the use of both ERT and HRT in women with CHD.2,6 The results of the Heart and Estrogen/progestin Replacement Study (HERS), which are reported by Hulley et al in this issue of JAMA,7 add critically important data on the effects of HRT. In this randomized controlled trial of 2763 postmenopausal women with established coronary disease, treatment with estrogen plus progestin did not reduce the rate of CHD events (eg, nonfatal myocardial infarction or CHD-related death). These findings are a sobering reminder of the limitations of observational research, the incompleteness of current understanding of the mechanisms of vascular disease, and the dangers of extrapolation.

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 94

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
CME Related by Topic
PubMed Articles